Envision

The in-office standard for precision periorbital treatments. Envision combines Bipolar RF and Intense Pulsed Light in a single intelligent workstation — delivering effective, non-drug therapies for Meibomian Gland Dysfunction, dry eye disease, ocular rosacea, and periorbital skin rejuvenation.

Periorbital PrecisionSmall-size applicators designed for safe treatment around the eyelids and delicate orbital tissue

Dual Modality PlatformBipolar RF (Forma-I) and IPL (Lumecca-I) working synergistically on one system

Intelligent Temperature ControlPrecision RF depth control and epidermal monitoring for safe peri-ocular delivery

No DowntimeNon-drug, non-surgical treatments with minimal recovery and same-day return to activity

Enquire Now

Clinically proven

SA distributor support

Training included

Areas Treated

Envision is specifically engineered for the periorbital region — the most delicate area of the face — with applicator sizes and energy delivery profiles designed for safe, precise treatment at and around the eyelids.

Meibomian Glands

Forma-I delivers targeted RF heating directly to blocked Meibomian glands, liquefying viscous secretions and restoring normal oil flow to stabilise the tear film

Upper & Lower Eyelids

Precision RF energy delivered to the upper and lower lids to reduce inflammation, stimulate collagen, and address glandular dysfunction with unprecedented periocular safety

Periorbital Skin

RF-based skin remodelling to address fine lines, crow's feet, and skin laxity in the immediate orbital region

Ocular Rosacea & Vascular Lesions

Lumecca-I IPL targets the inflammatory blood vessels associated with ocular rosacea, reducing redness and closing off abnormal capillaries

Pigmented Lesions

Spot-size IPL via Lumecca-I addresses benign epidermal pigmented lesions in the periorbital zone, optimised for skin types I–IV

Blepharitis & Demodex

Lumecca-I IPL has demonstrated clinical efficacy in reducing Demodex mites and bacteria around the eyelid margins

Platform Technologies

Envision deploys two complementary modalities — Bipolar RF and Intense Pulsed Light — each engineered with periocular-specific adaptors.

Bipolar RF

Forma-I

Forma-I delivers targeted bipolar radiofrequency energy to the periorbital area and eyelids via a compact, purpose-built applicator. Controlled thermal energy gently heats the Meibomian glands to melt viscous, impacted oil secretions — restoring normal gland function and healthy tear film production.

Intense Pulsed Light

Lumecca-I

Lumecca-I is a spot-size IPL adaptor enabling precise targeted light delivery in smaller periorbital zones. Using an advanced Xenon flash lamp optimised to produce 40% of total pulse energy in the 500–600nm range, IPL energy is selectively absorbed by melanin and haemoglobin chromophores.

Technical Specifications

Core technical parameters for the Envision platform. Contact your STERN Laser representative for full clinical and safety documentation.

Technologies	Bipolar Radiofrequency (Forma-I), Intense Pulsed Light (Lumecca-I)
Primary Indication	Meibomian Gland Dysfunction (MGD), Dry Eye Disease (DED), ocular rosacea, periorbital skin remodelling
Lumecca-I Skin Types	Fitzpatrick I–IV
Typical Session Duration	Forma-I: ~30 minutes \| Lumecca-I: 15–30 minutes
Recommended Protocol	4 treatments for optimal outcomes; maintenance 1–2× per year
Downtime	Minimal — mild redness may occur post-Lumecca-I, typically resolving within an hour
Intended Users	Ophthalmologists, optometrists, dermatologists, aesthetic clinicians

FAQs

Common questions about Envision treatments. Contact STERN Laser for clinical guidance specific to your practice.

Meibomian Gland Dysfunction (MGD) is the most common cause of dry eye disease, occurring when the oil-secreting glands in the eyelids become blocked. Forma-I uses bipolar RF energy to gently heat these glands, liquefying impacted secretions so they can be expressed. Lumecca-I IPL complements this by targeting the inflammatory blood vessels that perpetuate the MGD cycle.

Yes. Envision was specifically designed for periorbital use. Forma-I features precision RF depth control and real-time epidermal temperature monitoring. Lumecca-I includes integrated cooling and a spot-size adaptor for targeted IPL in smaller periorbital zones.

Yes, the two modalities are designed to be used together as a combined treatment protocol. Forma-I and Lumecca-I address different elements of MGD — RF targets gland function directly while IPL addresses the inflammatory vascular component — making their combination more effective than either used alone.

Modular Platform

Compatible Handpieces

Envision ships with two purpose-built periorbital handpieces — each delivering a different energy modality for a complementary, synergistic treatment protocol.